Note of the Recombinant Clotting Factors Working Group Meeting held on 9 September 2003 attended by Richard Gutowksi Dr Charles Hay and others. Discussion included Macfarlane Trust data the decision to roll-out recombinant products by age group and the hepatitis C payment scheme